glp-1 insurance coverage bcbs Medicaid of and Spending on GLP-1s Ro launches GLP-1 insurance coverage

Compared to baseline, patients who received the highest HRS-7535 dose of 90 mg demonstrated an HbA1c reduction of 1.68%

Chen S, Bao X, Chen H, Jia M, Li W, Zhang L, et al

Their benefits, such as improved glycaemic control, support for weight management, and potential cardiovascular protection, are well documented in clinical studies

In this review I aim to re-examine the contested concept of food addiction as a disease in the context of emerging GLP-1based obesity pharmacotherapies, integrating perspectives from neurobiology, societal impacts, and early evidence for their potential application in other substance-use disorders